Andy Bush, Ian D Pavord. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Administration, InhalationAdolescentAdultAge FactorsAnti-Asthmatic Agents/administration & dosageAnti-Asthmatic Agents/adverse effectsAntibodies, Anti-Idiotypic/administration & dosageAntibodies, Anti-Idiotypic/adverse effectsAntibodies, Monoclonal, Humanized/administration & dosageAntibodies, Monoclonal, Humanized/adverse effectsAsthma/drug therapyAsthma/immunologyChildFemaleGuideline AdherenceHumansMaleOmalizumabPractice Guidelines as TopicRisk AssessmentSeverity of Illness IndexTreatment OutcomeUnited KingdomYoung Adult
Substances: See more » Anti-Asthmatic AgentsAntibodies, Anti-IdiotypicAntibodies, Monoclonal, HumanizedOmalizumab
Year: 2013 PMID: 23229814 DOI: 10.1136/thoraxjnl-2012-202969
Source DB: PubMed Journal: Thorax ISSN: 0040-6376 Impact factor: 9.139